ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 6 of 365 for:    high intensity | Canada

Stair Climbing Outcomes in Cardiac Rehabilitation Exercise (SCORE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03235674
Recruitment Status : Recruiting
First Posted : August 1, 2017
Last Update Posted : March 29, 2018
Sponsor:
Information provided by (Responsible Party):
McMaster University

Brief Summary:
This study will evaluate the effect of brief, intermittent stair climbing exercise on key cardiovascular and metabolic markers of health in individuals completing a cardiac rehabilitation program. Participants of this study will be placed into one of two exercise groups: one group will perform the standard exercise protocol currently being used by the Cardiac Health and Rehabilitation Centre at Hamilton General Hospital and the second group will perform a variation of interval exercise training, high intensity interval stair climbing.

Condition or disease Intervention/treatment Phase
Endothelial Dysfunction Other: High-intensity stair climbing exercise Not Applicable

Detailed Description:
Cardiac rehabilitation (CR) is a recognized health service for the secondary prevention of CVD, unfortunately, CR is vastly underutilized, due to low referral rates and patient-related factors such as time commitment, travelling distance or user fees. After 2 weeks of CR exercise prescription, ~80% of patients opt to exercise independently rather than join a structured rehabilitation program in the community, suggesting that alternatives for current centre-based CR should focus on at-home programming with the intention of enhancing adherence and maintaining the lifestyle benefits long-term. The implementation of high-intensity interval exercise in CR programming has proven to be time-effective, enjoyable, safe, and capable of inducing similar if not superior cardiorespiratory responses, when compared to traditional, continuous CR programs. Recently, the benefits of interval stair climbing exercise in sedentary women were established, in that completing 3, 60 second bouts of high intensity stair climbing, 3 days/week for 6 weeks improved cardiorespiratory fitness, and represents a model of low-volume high-intensity interval training which is tolerable, effective and easily accessible for sedentary adults.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: A Feasible High Intensity Interval Exercise Training Intervention in Phase II Cardiac Rehabilitation
Actual Study Start Date : January 30, 2018
Estimated Primary Completion Date : February 2019
Estimated Study Completion Date : May 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: High-intensity stair climbing exercise
3 x 60 seconds of stair climbing, at a vigorous pace as described by rating of perceived exertion, separated by 60 seconds of rest. Subjects will complete supervised sessions 3 times/week for 2 weeks, and then continue unsupervised for the following 10 weeks.
Other: High-intensity stair climbing exercise
High intensity stair climbing exercise at a vigorous pace as measured by rating of perceived exertion.

No Intervention: standard cardiac rehabilitation exercise
Subjects will complete the traditional cardiac rehabilitation program, combination of aerobic and resistance exercise 2 times/week for 2 weeks, and then continue unsupervised for the following 10 weeks.



Primary Outcome Measures :
  1. brachial endothelial function as measured by flow-mediated dilation (FMD) [ Time Frame: Change from baseline FMD at 12 weeks ]
    This technique involves the placement of a blood pressure cuff around the forearm distal to the olecranon process (elbow). The cuff is inflated above systolic blood pressure to ~200 mmHg (in order to attain cessation of arm blood flow) and is held at this pressure for a period of five minutes. Continual measures of brachial artery diameter and blood flow velocity will be obtained using Doppler ultrasound. A 10 MHz probe will be placed on the upper arm (below the biceps) and moved around until the best signal is found. Images of brachial artery diameter and blood flow velocity will be taken at rest (before cuff inflation), prior to cuff deflation (end of five minute ischemic period), and following cuff deflation for two minutes.


Secondary Outcome Measures :
  1. cardiorespiratory fitness [ Time Frame: Change from baseline stress test at 12 weeks ]
    Maximal aerobic capacity will be determined using a medically monitored exercise stress test.

  2. skeletal muscle capillary content [ Time Frame: change from baseline capillary content at 12 weeks ]
    Muscle capillaries will be detected in frozen cross-sections of muscle biopsies based on positive staining with fluorescent lectin Ulex europaeus, and quantified relative to muscle fibre number (capillary:fibre ratio).

  3. cardiac diastolic function [ Time Frame: change from baseline left ventricular values at 12 weeks ]
    The heart must be imaged at both the base (top) and apex (bottom) of the left ventricle. Images will be taken in the parasternal short axis view with the participant lying in the left lateral decubitus position to allow the expansion of the rib cage and proper orientation of the heart within the chest cavity. Doppler ultrasound (5MHz sector probe) will be applied to the upper-middle section of the chest for the best images. Basal images will be taken at the tips of the mitral valves, while apical images will be taken at the most distal aspect of the left ventricle, with the LV cavity representing ~50% of the left ventricle wall thickness.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Men and (post-menopausal) women
  • Registered to participate in the Cardiac Health and Rehabilitation Centre (CHRC) at the Hamilton Health Sciences General Division
  • History of previous myocardial infarction, coronary artery bypass graft, and/or percutaneous coronary intervention
  • Non-smoker (within 3-months)
  • Local resident, with transportation to the CHRC at the Hamilton Health Sciences General Division.
  • Ability to understand written and verbal instructions and provide written informed consent.
  • Stable medical therapy.

Exclusion Criteria:

  • Non-cardiac surgical procedure within two months
  • Positive exercise stress test (i.e. typical symptoms of chest discomfort and ECG changes or positive nuclear scan)
  • Myocardial infarction within two months; coronary artery bypass graft surgery within two months; percutaneous coronary intervention within one month
  • Baseline work capacity < 25 W
  • NYHA class II-IV symptoms of heart failure
  • Documented significant valve stenosis
  • Symptomatic peripheral arterial disease that limits exercise capacity
  • Uncontrolled supraventricular or ventricular dysrhythmia
  • Unstable angina
  • Uncontrolled hypertension (blood pressure >160/90 mmHg)
  • Documented chronic obstructive pulmonary disease (FEV1 <60% and/or FVC <60%)
  • Any musculoskeletal abnormality that would limit exercise participation

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03235674


Contacts
Contact: Emily C Dunford, PhD 905-517-2273 dunforde@mcmaster.ca
Contact: Maureen J MacDonald, PhD macdonmj@mcmaster.ca

Locations
Canada, Ontario
Cardiac Health and Rehabilitation Centre Recruiting
Hamilton, Ontario, Canada
Contact: Emily Dunford    9055172273    dunforde@mcmaster.ca   
Sponsors and Collaborators
McMaster University
Investigators
Principal Investigator: Maureen J MacDonald, PhD McMaster University

Publications:
Responsible Party: McMaster University
ClinicalTrials.gov Identifier: NCT03235674     History of Changes
Other Study ID Numbers: SCORE
First Posted: August 1, 2017    Key Record Dates
Last Update Posted: March 29, 2018
Last Verified: August 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by McMaster University:
Cardiac rehabilitation
interval exercise